Literature DB >> 12238646

Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India.

A Risbud1, S Mehendale, S Basu, S Kulkarni, A Walimbe, V Arankalle, R Gangakhedkar, A Divekar, R Bollinger, D Gadkari, R Paranjape.   

Abstract

OBJECTIVES: To estimate the prevalence and incidence of hepatitis B virus (HBV) infection among patients attending three STD clinics in Pune, India, and to identify associated risk factors.
METHODS: Of the 2098 patients screened at STD clinics in Pune during 1996, 497, who returned for at least one follow up visit, were screened for various markers of HBV infection (HBsAg, anti-HBs, anti-HBc), HIV antibody, and VDRL.
RESULTS: Of the 497 participants 3.6%, 26.5%, and 43.2% were positive for HBsAg, anti-HBs, and anti-HBc respectively. Tattooing (AOR 1.64, 95% CI 1.03 to 2.64) was found to be independently associated with presence of core antibody. Additionally, history of being in commercial sex work and history of a genital ulcer were independently associated with a positive anti-HBc antibody test (AOR 12.45, 95% CI 5.58 to 27.82 and AOR 1.70, 95% CI 1.09 to 2.66, respectively). 72 out of 497 (14.5%) participants were HIV positive at baseline. HIV-1 antibody positive patients were more likely to have a positive anti-HBc test (69.4% v 39.0%, p<0.001). 30 out of 282 participants, negative for anti-HBc antibody at enrolment, seroconverted subsequently, resulting in an incidence of 10.86 per 100 person years (95% CI 7.2%, 14.5%) (mean and accumulated follow up of 11.7 months and 276.17 person years, respectively).
CONCLUSIONS: A high prevalence and incidence of HBV infection, seen in STD clinic attendees underscore the need to provide HBV vaccine to commercial sex workers and their clients in India.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12238646      PMCID: PMC1744470          DOI: 10.1136/sti.78.3.169

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  17 in total

1.  Necessity to vaccinate spouses of hepatitis B patients and carriers.

Authors:  V A Arankalle; M S Chadha; K Banerjee
Journal:  J Assoc Physicians India       Date:  1990-07

2.  Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B.

Authors:  P Levy; P Marcellin; M Martinot-Peignoux; C Degott; J Nataf; J P Benhamou
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

3.  Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.

Authors:  M G Brook; G Chan; I Yap; P Karayiannis; A M Lever; M Jacyna; J Main; H C Thomas
Journal:  BMJ       Date:  1989-09-09

4.  Coincidence of hepatitis B-virus markers and other sexually transmitted diseases in different STD-risk groups.

Authors:  A Stary; W Kopp; C Heller-Vitouch
Journal:  Zentralbl Bakteriol       Date:  1992-04

5.  Evidence for high prevalence & rapid transmission of HIV among individuals attending STD clinics in Pune, India.

Authors:  S M Mehendale; M E Shepherd; A D Divekar; R R Gangakhedkar; S S Kamble; P A Menon; R Yadav; A R Risbud; R S Paranjape; D A Gadkari; T C Quinn; R C Bollinger; J J Rodrigues
Journal:  Indian J Med Res       Date:  1996-12       Impact factor: 2.375

6.  [Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus].

Authors:  F Denis; C C Adjide; S Rogez; C Delpeyroux; J P Rogez; P Weinbreck
Journal:  Pathol Biol (Paris)       Date:  1997-11

7.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.

Authors:  S C Hadler; F N Judson; P M O'Malley; N L Altman; K Penley; S Buchbinder; C A Schable; P J Coleman; D N Ostrow; D P Francis
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

8.  Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.

Authors:  B Broers; C Junet; M Bourquin; J J Déglon; L Perrin; B Hirschel
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

9.  Hepatitis B virus transmission between heterosexuals.

Authors:  M J Alter; J Ahtone; I Weisfuse; K Starko; T D Vacalis; J E Maynard
Journal:  JAMA       Date:  1986-09-12       Impact factor: 56.272

10.  Risk factors for hepatitis B virus infection in heterosexuals attending a venereal disease clinic in Copenhagen.

Authors:  B B Kvinesdal; A M Worm; A Gottschau
Journal:  Scand J Infect Dis       Date:  1993
View more
  14 in total

1.  Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India.

Authors:  L Jagannathan; M Chaturvedi; S Mudaliar; T Kamaladoss; M Rice; E L Murphy
Journal:  Transfus Med       Date:  2010-08-18       Impact factor: 2.019

Review 2.  Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV.

Authors:  Robert C Bollinger; Chloe L Thio; Mark S Sulkowski; Jane McKenzie-White; David L Thomas; Charles Flexner
Journal:  Lancet HIV       Date:  2019-12-20       Impact factor: 12.767

3.  Seroprevalence of Hepatitis B Virus and Associated Factors Among Female Sex Workers Using Respondent-Driven Sampling in Hawassa City, Ethiopia.

Authors:  Deresse Daka; Getahun Hailemeskel; Demissie Assegu Fenta
Journal:  Infect Drug Resist       Date:  2021-10-20       Impact factor: 4.003

4.  Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario.

Authors:  Nilanjan Chakraborty; Sohinee Bhattacharyya; Chandrav De; Anirban Mukherjee; Dwipayan Bhattacharya; Shantanu Santra; Rathindra N Sarkar; Dipanjan Banerjee; Shubhasish K Guha; Utpal K Datta; Sekhar Chakrabarti
Journal:  Virol J       Date:  2010-07-06       Impact factor: 4.099

5.  Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

Authors:  Rita B Effros; Courtney V Fletcher; Kelly Gebo; Jeffrey B Halter; William R Hazzard; Frances McFarland Horne; Robin E Huebner; Edward N Janoff; Amy C Justice; Daniel Kuritzkes; Susan G Nayfield; Susan F Plaeger; Kenneth E Schmader; John R Ashworth; Christine Campanelli; Charles P Clayton; Beth Rada; Nancy F Woolard; Kevin P High
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

6.  Prevalence and incidence of sexually transmitted infections among South Indians at increased risk of HIV infection.

Authors:  N Kumarasamy; P Balakrishnan; K K Venkatesh; A K Srikrishnan; A J Cecelia; E Thamburaj; S Solomon; K H Mayer
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

7.  Evaluation of adefovir & lamivudine in chronic hepatitis B: correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis.

Authors:  S Pradeep Kumar; Subhash Medhi; Mohammad Asim; Bhudev C Das; Ranjana Gondal; Premashis Kar
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

8.  Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.

Authors:  Savanna Reid
Journal:  Indian J Community Med       Date:  2012-04

9.  A Cross-Sectional Study of Anti-Hepatitis B Antibody Status in STD Patients: Need for Improved Immunization.

Authors:  Bineeta Kashyap; Chander Grover; Amit Dhawan; Sambit Nath Bhattacharya; Iqbal Rajinder Kaur; Shukla Das
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

10.  Sexual slavery without borders: trafficking for commercial sexual exploitation in India.

Authors:  Christine Joffres; Edward Mills; Michel Joffres; Tinku Khanna; Harleen Walia; Darrin Grund
Journal:  Int J Equity Health       Date:  2008-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.